NCT00361855View on ClinicalTrials.gov

Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Conditions
Myocardial Infarction
Interventions
DRUG

NX-CP105

Trial Locations (5)

15213

University of Pittsburgh Medical Center, Pittsburgh

55407

Minneapolis Heart Institute Foundation, Minneapolis

60611

Northwestern University, Chicago

85006

Arizona Heart Institute, Phoenix

92037

Scripps Clinic, La Jolla

Sponsors

Lead Sponsor

Neuronyx
All Listed Sponsors
lead

Neuronyx

INDUSTRY